Stem Cell Sciences plc has announced an agreement with Myelin Repair Foundation (MRF) to develop methods for generating sustainable cultures of human brain cells. Under the terms of the agreement, MRF will work on developing methods for culturing neural stem cells, and inducing the stem cells to differentiate into neurons, oligodendrocytes, and astrocytes. The cultures and techniques developed through the agreement should be useful for research, validating targets, and drug screening studies. Although Stem Cell Sciences will have the first right of negotiation with respect to commercializing any potential products that are derived 
under the agreement, the parties are hoping that the neuroscience community at large will benefit from the source of brain cells and methods discovered during the collaboration.
Stem Cell Sciences is a research and development company that focuses on stem cell research. The company's mission is to discover and develop stem cell-based therapeutics.
Myelin Repair Foundation is a non-profit organization that is focused on research and development of myelin repair therapeutics for the treatment of multiple sclerosis and other neurological diseases.
Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.
Comments